NCT01435993View on ClinicalTrials.gov

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

PHASE1TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

September 8, 2011

Primary Completion Date

January 23, 2012

Study Completion Date

January 23, 2012

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

GSK1223249

Intravenous infusion

OTHER

Saline placebo

placebo intravenous infusion

Trial Locations (2)

1478

GSK Investigational Site, Lørenskog

37134

GSK Investigational Site, Verona

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY